{
    "nctId": "NCT03005860",
    "briefTitle": "Effect of TIVA Propofol vs Sevoflurane Anaesthetic on Serum Biomarkers and on PBMCs in Breast Cancer Surgery",
    "officialTitle": "A Prospective, Randomized, Controlled Trial to Compare the Effect of TIVA Propofol vs Sevoflurane Anaesthetic on Serumserum Biomarkers and on PBMCs in Patients Undergoing Breast Cancer Resection Surgery",
    "overallStatus": "WITHDRAWN",
    "conditions": "Female Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 0,
    "primaryOutcomeMeasure": "Change in baseline levels versus 24 hour postoperative levels (Tpre vs T24h ) of serum HIF-1a and VEGF-C in both groups.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Women with histopathologically (biopsy/FNAC) proven breast carcinoma with Resectable disease (T 1-4, N 0-1, M 0) \\[Stage I-III\\].\n2. Willing for upfront modified radical mastectomy.\n3. ASA Physical Status 1-2\n\nExclusion Criteria:\n\n1. use of morphine or on steroid therapy upto 3 months before surgery;\n2. history of substance abuse or cognitive dysfunction;\n3. endocrine disorders- diabetes, hypothyroid;\n4. history of HIV, Hep-B or Hep-C infections;\n5. Contraindication to analgesics or anaesthetic drugs;\n6. Pregnant \\& lactating women",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}